1 0

    FDA NDA 214755: Review Files for the supplemental NDA application for Lumryz

    FDA NDA 214755: Review Files for the supplemental NDA application for Lumryz

    $9.95 USD
    $9.95 USD
    Sale Sold out

    Contents: Review files for the supplemental NDA application for Lumryz (NDA #214755) related to the September 26, 2024 approval for inclusion of a starter pack.

    New Drug Application (NDA): 214755
    Company: AVADEL CNS
    Action Date: 05/01/2023

    224 pages

    PUBLICLY AVAILABLE (we charge a convenience fee for download)
    View full details